Literature DB >> 28097648

A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder.

A Ratheesh1,2, C Davey1,2, S Hetrick1,2, M Alvarez-Jimenez1,2, C Voutier3, A Bechdolf4,5, P D McGorry1,2, J Scott6, M Berk1,2,7,8, S M Cotton1,2.   

Abstract

OBJECTIVE: Some people with major depressive disorder (MDD) may be at a pre-onset stage for bipolar disorder (BD), where early identification or prevention efforts may be feasible. We aimed to identify rates and characteristics predictive of transition to BD in prospective follow-up studies of people with MDD.
METHODS: Using a systematic search strategy, we identified studies with a diagnostic ascertainment of MDD and BD of an adequate standard, and where the minimum length of follow-up was 6 months. We examined the incidence and point prevalence of BD and the pooled odds ratios (OR) for baseline predictors.
RESULTS: From 5554 unique publications, 56 were included. Nearly a quarter of adults (22.5%) and adolescents with MDD followed up for a mean length of 12-18 years developed BD, with the greatest risk of transition being in the first 5 years. The meta-analysis identified that transition from MDD to BD was predicted by family history of BD (OR = 2.89, 95% CI: 2.01-4.14, N = 7), earlier age of onset of depression (g = -0.33, SE = 0.05, N = 6) and presence of psychotic symptoms (OR = 4.76, 95% CI: 1.79-12.66, N = 5).
CONCLUSIONS: Participants with the identified risk factors merit closer observation and may benefit from prevention efforts, especially if outcomes broader than BD are considered.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  affective disorders; bipolar disorder; depression; meta-analysis; risk factors

Mesh:

Year:  2017        PMID: 28097648     DOI: 10.1111/acps.12686

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  15 in total

1.  Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.

Authors:  Robert K McNamara; Jeffrey R Strawn; Max J Tallman; Jeffrey A Welge; L Rodrigo Patino; Thomas J Blom; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 3.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime.

Authors:  Diego de la Vega; Ana Piña; Francisco J Peralta; Sam A Kelly; Lucas Giner
Journal:  Curr Psychiatry Rep       Date:  2018-04-02       Impact factor: 5.285

4.  Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population.

Authors:  Katherine L Musliner; Preben B Mortensen; John J McGrath; Nis P Suppli; David M Hougaard; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Ole Andreassen; Carsten B Pedersen; Marianne G Pedersen; Ole Mors; Merete Nordentoft; Anders D Børglum; Thomas Werge; Esben Agerbo
Journal:  JAMA Psychiatry       Date:  2019-05-01       Impact factor: 21.596

5.  The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls.

Authors:  Jonathan R I Coleman; Héléna A Gaspar; Julien Bryois; Gerome Breen
Journal:  Biol Psychiatry       Date:  2019-11-01       Impact factor: 13.382

6.  Preventive psychiatry: a blueprint for improving the mental health of young people.

Authors:  Paolo Fusar-Poli; Christoph U Correll; Celso Arango; Michael Berk; Vikram Patel; John P A Ioannidis
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 79.683

7.  Aberrant Neural Activity in Patients With Bipolar Depressive Disorder Distinguishing to the Unipolar Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  Meihui Qiu; Huifeng Zhang; David Mellor; Jun Shi; Chuangxin Wu; Yueqi Huang; Jianye Zhang; Ting Shen; Daihui Peng
Journal:  Front Psychiatry       Date:  2018-06-05       Impact factor: 4.157

8.  Emotion-Related Network Reorganization Following Fish Oil Supplementation in Depressed Bipolar Offspring: An fMRI Graph-Based Connectome Analysis.

Authors:  Wenbin Li; Du Lei; Maxwell J Tallman; L Rodrigo Patino; Qiyong Gong; Jeffrey R Strawn; Melissa P DelBello; Robert K McNamara
Journal:  J Affect Disord       Date:  2021-06-05       Impact factor: 6.533

9.  Applying dimensional psychopathology: transdiagnostic associations among regional homogeneity, leptin and depressive symptoms.

Authors:  Yanqing Tang; Fei Wang; Yan-Ge Wei; Jia Duan; Fay Y Womer; Yue Zhu; Zhiyang Yin; Lingling Cui; Chao Li; Zhuang Liu; Shengnan Wei; Xiaowei Jiang; Yanbo Zhang; Xizhe Zhang
Journal:  Transl Psychiatry       Date:  2020-07-22       Impact factor: 6.222

10.  Risk Stratification for Bipolar Disorder Using Polygenic Risk Scores Among Young High-Risk Adults.

Authors:  Silvia Biere; Thorsten M Kranz; Silke Matura; Kristiyana Petrova; Fabian Streit; Andreas G Chiocchetti; Oliver Grimm; Murielle Brum; Natalie Brunkhorst-Kanaan; Viola Oertel; Aliaksandr Malyshau; Andrea Pfennig; Michael Bauer; Thomas G Schulze; Sarah Kittel-Schneider; Andreas Reif
Journal:  Front Psychiatry       Date:  2020-10-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.